ClinicalTrials.Veeva

Menu

Aromatherapy in Reducing PONV for Total Joint Replacement Patients (RCT PONV)

H

Hong Kong Buddhist Hospital

Status

Enrolling

Conditions

Postoperative Nausea and Vomiting
Total Joint Replacement Surgery

Treatments

Other: Placebo Patches
Other: Aromatherapy patches
Drug: Control (Standard treatment)

Study type

Interventional

Funder types

Other

Identifiers

NCT07281885
CIRB-2025-242-5

Details and patient eligibility

About

This study investigates the effectiveness of aromatherapy in reducing postoperative nausea and vomiting (PONV) among patients undergoing total joint replacement surgery, as these complications can lead to patient discomfort and prolonged recovery. It is designed as a randomized controlled trial involving 159 participants, who will be divided into three groups: an intervention group receiving aromatherapy patches (lavender-sandalwood or orange-ginger) plus standard care, a placebo group with a placebo patch plus standard care, and a control group receiving standard care alone. PONV will be measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) at baseline, 30 minutes after the intervention, and every 12 hours post-surgery. Additionally, patient satisfaction will be assessed through a 5-point Likert scale survey. The primary outcome of the study is the evaluation of RINVR scores, while the secondary outcome focuses on patient satisfaction levels. Data will be statistically analyzed using two-way ANOVA for repeated measures, with a significance level defined as p < 0.05. The study aims to determine the viability of aromatherapy as a complementary treatment for PONV, potentially improving postoperative care, enhancing patient satisfaction, and offering a cost-effective alternative to conventional anti emetic treatments if proven effective.

Enrollment

159 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 or above
  • Patients scheduled for total joint replacement surgery at the HKBH

Exclusion criteria

  • Cognitive impairments
  • Allergy to lavender, orange, ginger, or sandalwood
  • Allergy to micro-pore tape
  • Allergy to opioid medication
  • Undergoing other therapeutic treatment for PONV control, except prescribed medications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

159 participants in 3 patient groups, including a placebo group

Aromatherapy patches
Experimental group
Description:
Standard Care + Use of Aromatherapy Patches
Treatment:
Other: Aromatherapy patches
Placebo patches
Placebo Comparator group
Description:
Standard Care + Use of Placebo Patches
Treatment:
Other: Placebo Patches
Prescribed antiemetic treatment
Active Comparator group
Description:
As standard care alone
Treatment:
Drug: Control (Standard treatment)

Trial contacts and locations

1

Loading...

Central trial contact

Victor CHEUNG, EOII(MDSSC); Choi Wan CHAN, APN (NURSING)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems